Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare ltd. - isosorbidmononitrat - tablett - 20 mg - isosorbidmononitrat 20 mg aktiv substans; laktosmonohydrat hjälpämne - isosorbidmononitrat

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare ltd. - topotekanhydroklorid - pulver till koncentrat till infusionsvätska, lösning - 4 mg - mannitol hjälpämne; topotekanhydroklorid 4,346 mg aktiv substans - topotekan

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare ltd. - omeprazol - enterokapsel, hård - 20 mg - sockersfärer hjälpämne; laktos (vattenfri) hjälpämne; natriumlaurilsulfat hjälpämne; omeprazol 20 mg aktiv substans - omeprazol

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare ltd. - omeprazol - enterokapsel, hård - 40 mg - laktos (vattenfri) hjälpämne; omeprazol 40 mg aktiv substans; natriumlaurilsulfat hjälpämne; sockersfärer hjälpämne - omeprazol

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare ltd. - oxikodonhydroklorid - depottablett - 10 mg - propylenglykol hjälpämne; sockersfärer hjälpämne; oxikodonhydroklorid 2 mg aktiv substans; oxikodonhydroklorid 8 mg aktiv substans - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare ltd. - oxikodonhydroklorid - depottablett - 20 mg - oxikodonhydroklorid 16 mg aktiv substans; oxikodonhydroklorid 4 mg aktiv substans; sockersfärer hjälpämne; propylenglykol hjälpämne - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare ltd. - oxikodonhydroklorid - depottablett - 40 mg - oxikodonhydroklorid 32 mg aktiv substans; oxikodonhydroklorid 8 mg aktiv substans; sockersfärer hjälpämne; propylenglykol hjälpämne - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare ltd. - oxikodonhydroklorid - depottablett - 5 mg - sockersfärer hjälpämne; propylenglykol hjälpämne; oxikodonhydroklorid 4 mg aktiv substans; oxikodonhydroklorid 1 mg aktiv substans - oxikodon